Delta plus, detected in Europe, is not variant of concern yet: Govt

As per data available in public domain, this variant nullifies the use of monoclonal antibody, says V K Paul, member (health) of NITI Aayog

Coronavirus mutation, coronavirus strain, coronavirus variant
Photo: Shutterstock
BS Web Team New Delhi
2 min read Last Updated : Jun 15 2021 | 5:37 PM IST
The union government on Tuesday said that a new "variant of interest" has been found outside the country, that is an additional mutation to the now dominant Delta variant.

"Delta variant played major a role in the second wave. An additional mutation of this variant, namely Delta Plus, has been found and submitted to global data system," Dr V K Paul, member of NITI Aayog has said.

"It has emerged in Europe in March and was brought into the public domain on June 13," Dr VK Paul added.

However, Dr Paul said that this new Delta Plus strain is yet to be classified as a "variant of concern," adding that the government is keeping a close eye on the progress of the said variant.

"As per data available in public domain, this variant nullifies the use of monoclonal antibody. We will study and learn more about this," Dr Paul further said.

Addressing a press briefing on the coronavirus situation in India, government officials said that the country has seen a massive drop in daily cases but cautioned against letting the guard down so as to not fritter away the gains.

"There has been an almost 85 per cent decline in daily Covid-19 cases since the highest reported peak on May 7 and currently, there are 20 states and UTs where active cases are less than 5,000," Lav Agarwal, Joint Secretary of the Health Ministry, said.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story